Observational studyThe oncologist2026

Comparative safety of concurrent adjuvant trastuzumab emtansine vs trastuzumab with radiotherapy in HER2-positive early breast cancer.

Mine Aysan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.